ID   GPAT1_HUMAN             Reviewed;         828 AA.
AC   Q9HCL2; Q5VW51; Q86TA3;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 3.
DT   28-JUN-2023, entry version 179.
DE   RecName: Full=Glycerol-3-phosphate acyltransferase 1, mitochondrial {ECO:0000305};
DE            Short=GPAT-1;
DE            EC=2.3.1.15 {ECO:0000269|PubMed:18238778};
DE   Flags: Precursor;
GN   Name=GPAM {ECO:0000312|HGNC:HGNC:24865}; Synonyms=GPAT1, KIAA1560;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Spinal cord;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 167-828.
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [5]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=18238778; DOI=10.1074/jbc.m708151200;
RA   Chen Y.Q., Kuo M.-S., Li S., Bui H.H., Peake D.A., Sanders P.E.,
RA   Thibodeaux S.J., Chu S., Qian Y.-W., Zhao Y., Bredt D.S., Moller D.E.,
RA   Konrad R.J., Beigneux A.P., Young S.G., Cao G.;
RT   "AGPAT6 is a novel microsomal glycerol-3-phosphate acyltransferase.";
RL   J. Biol. Chem. 283:10048-10057(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-695, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [7]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=19075029; DOI=10.1194/jlr.m800567-jlr200;
RA   Zhao Y., Chen Y.-Q., Li S., Konrad R.J., Cao G.;
RT   "The microsomal cardiolipin remodeling enzyme acyl-CoA lysocardiolipin
RT   acyltransferase is an acyltransferase of multiple anionic
RT   lysophospholipids.";
RL   J. Lipid Res. 50:945-956(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-695, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Esterifies acyl-group from acyl-ACP to the sn-1 position of
CC       glycerol-3-phosphate, an essential step in glycerolipids biosynthesis
CC       such as triglycerides, phosphatidic acids and lysophosphatidic acids.
CC       {ECO:0000269|PubMed:18238778}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an acyl-CoA + sn-glycerol 3-phosphate = a 1-acyl-sn-glycero-3-
CC         phosphate + CoA; Xref=Rhea:RHEA:15325, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57597, ChEBI:CHEBI:57970, ChEBI:CHEBI:58342; EC=2.3.1.15;
CC         Evidence={ECO:0000269|PubMed:18238778};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15326;
CC         Evidence={ECO:0000305|PubMed:18238778};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + sn-glycerol 3-phosphate = 1-
CC         (9Z,12Z)-octadecadienoyl-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:37203, ChEBI:CHEBI:57287, ChEBI:CHEBI:57383,
CC         ChEBI:CHEBI:57597, ChEBI:CHEBI:74547;
CC         Evidence={ECO:0000269|PubMed:18238778};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37204;
CC         Evidence={ECO:0000305|PubMed:18238778};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + sn-glycerol 3-phosphate = 1-(9Z-
CC         octadecenoyl)-sn-glycero-3-phosphate + CoA; Xref=Rhea:RHEA:37199,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, ChEBI:CHEBI:57597,
CC         ChEBI:CHEBI:74544; Evidence={ECO:0000269|PubMed:18238778};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37200;
CC         Evidence={ECO:0000305|PubMed:18238778};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=octadecanoyl-CoA + sn-glycerol 3-phosphate = 1-octadecanoyl-
CC         sn-glycero-3-phosphate + CoA; Xref=Rhea:RHEA:37195,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57394, ChEBI:CHEBI:57597,
CC         ChEBI:CHEBI:74565; Evidence={ECO:0000269|PubMed:18238778};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37196;
CC         Evidence={ECO:0000305|PubMed:18238778};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexadecanoyl-CoA + sn-glycerol 3-phosphate = 1-hexadecanoyl-
CC         sn-glycero-3-phosphate + CoA; Xref=Rhea:RHEA:35723,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57379, ChEBI:CHEBI:57518,
CC         ChEBI:CHEBI:57597; Evidence={ECO:0000269|PubMed:18238778};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35724;
CC         Evidence={ECO:0000305|PubMed:18238778};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanoyl-CoA + sn-glycerol 3-phosphate = 1-dodecanoyl-sn-
CC         glycerol 3-phosphate + CoA; Xref=Rhea:RHEA:35727, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57375, ChEBI:CHEBI:57597, ChEBI:CHEBI:72682;
CC         Evidence={ECO:0000269|PubMed:18238778};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35728;
CC         Evidence={ECO:0000305|PubMed:18238778};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-acyl-sn-glycero-3-phospho-(1'-sn-glycerol) + an acyl-CoA =
CC         1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) + CoA;
CC         Xref=Rhea:RHEA:33203, ChEBI:CHEBI:57287, ChEBI:CHEBI:58342,
CC         ChEBI:CHEBI:64716, ChEBI:CHEBI:64840;
CC         Evidence={ECO:0000269|PubMed:19075029};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33204;
CC         Evidence={ECO:0000269|PubMed:19075029};
CC   -!- PATHWAY: Phospholipid metabolism; CDP-diacylglycerol biosynthesis; CDP-
CC       diacylglycerol from sn-glycerol 3-phosphate: step 1/3.
CC       {ECO:0000269|PubMed:18238778}.
CC   -!- INTERACTION:
CC       Q9HCL2; Q9UHD4: CIDEB; NbExp=3; IntAct=EBI-7600236, EBI-7062247;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane
CC       {ECO:0000250|UniProtKB:P97564}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P97564}.
CC   -!- DOMAIN: The HXXXXD motif is essential for acyltransferase activity and
CC       may constitute the binding site for the phosphate moiety of the
CC       glycerol-3-phosphate. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the GPAT/DAPAT family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL833093; CAD89932.1; -; mRNA.
DR   EMBL; AL391986; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB046780; BAB13386.1; -; mRNA.
DR   CCDS; CCDS7570.1; -.
DR   RefSeq; NP_001231878.1; NM_001244949.1.
DR   RefSeq; NP_065969.3; NM_020918.5.
DR   RefSeq; XP_005270055.1; XM_005269998.1.
DR   PDB; 8E4Y; EM; 3.40 A; A=80-828.
DR   PDB; 8E50; EM; 3.67 A; A=80-828.
DR   PDBsum; 8E4Y; -.
DR   PDBsum; 8E50; -.
DR   AlphaFoldDB; Q9HCL2; -.
DR   SMR; Q9HCL2; -.
DR   BioGRID; 121707; 35.
DR   IntAct; Q9HCL2; 12.
DR   MINT; Q9HCL2; -.
DR   STRING; 9606.ENSP00000265276; -.
DR   BindingDB; Q9HCL2; -.
DR   ChEMBL; CHEMBL3734642; -.
DR   SwissLipids; SLP:000000094; -.
DR   GlyGen; Q9HCL2; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9HCL2; -.
DR   PhosphoSitePlus; Q9HCL2; -.
DR   SwissPalm; Q9HCL2; -.
DR   BioMuta; GPAM; -.
DR   DMDM; 59803040; -.
DR   EPD; Q9HCL2; -.
DR   jPOST; Q9HCL2; -.
DR   MassIVE; Q9HCL2; -.
DR   MaxQB; Q9HCL2; -.
DR   PaxDb; Q9HCL2; -.
DR   PeptideAtlas; Q9HCL2; -.
DR   ProteomicsDB; 81752; -.
DR   Antibodypedia; 31772; 263 antibodies from 30 providers.
DR   DNASU; 57678; -.
DR   Ensembl; ENST00000348367.9; ENSP00000265276.4; ENSG00000119927.14.
DR   GeneID; 57678; -.
DR   KEGG; hsa:57678; -.
DR   MANE-Select; ENST00000348367.9; ENSP00000265276.4; NM_001244949.2; NP_001231878.1.
DR   UCSC; uc001kzp.4; human.
DR   AGR; HGNC:24865; -.
DR   CTD; 57678; -.
DR   DisGeNET; 57678; -.
DR   GeneCards; GPAM; -.
DR   HGNC; HGNC:24865; GPAM.
DR   HPA; ENSG00000119927; Tissue enhanced (adipose tissue, liver).
DR   MIM; 602395; gene.
DR   neXtProt; NX_Q9HCL2; -.
DR   OpenTargets; ENSG00000119927; -.
DR   PharmGKB; PA134983031; -.
DR   VEuPathDB; HostDB:ENSG00000119927; -.
DR   eggNOG; KOG3729; Eukaryota.
DR   GeneTree; ENSGT00520000055570; -.
DR   InParanoid; Q9HCL2; -.
DR   OMA; RCKHTNE; -.
DR   OrthoDB; 2874405at2759; -.
DR   PhylomeDB; Q9HCL2; -.
DR   TreeFam; TF313360; -.
DR   BioCyc; MetaCyc:57678-MON; -.
DR   BRENDA; 2.3.1.15; 2681.
DR   PathwayCommons; Q9HCL2; -.
DR   Reactome; R-HSA-1483166; Synthesis of PA.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   Reactome; R-HSA-75109; Triglyceride biosynthesis.
DR   Reactome; R-HSA-8931987; RUNX1 regulates estrogen receptor mediated transcription.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   SignaLink; Q9HCL2; -.
DR   UniPathway; UPA00557; UER00612.
DR   BioGRID-ORCS; 57678; 11 hits in 1159 CRISPR screens.
DR   ChiTaRS; GPAM; human.
DR   GeneWiki; GPAM; -.
DR   GenomeRNAi; 57678; -.
DR   Pharos; Q9HCL2; Tbio.
DR   PRO; PR:Q9HCL2; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q9HCL2; protein.
DR   Bgee; ENSG00000119927; Expressed in pericardium and 179 other tissues.
DR   ExpressionAtlas; Q9HCL2; baseline and differential.
DR   Genevisible; Q9HCL2; HS.
DR   GO; GO:0031966; C:mitochondrial membrane; IBA:GO_Central.
DR   GO; GO:0005741; C:mitochondrial outer membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IEA:InterPro.
DR   GO; GO:0004366; F:glycerol-3-phosphate O-acyltransferase activity; IMP:UniProtKB.
DR   GO; GO:0102420; F:sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050798; P:activated T cell proliferation; IEA:Ensembl.
DR   GO; GO:0006924; P:activation-induced cell death of T cells; IEA:Ensembl.
DR   GO; GO:0006637; P:acyl-CoA metabolic process; IEA:Ensembl.
DR   GO; GO:0016024; P:CDP-diacylglycerol biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0051607; P:defense response to virus; IEA:Ensembl.
DR   GO; GO:0006651; P:diacylglycerol biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0055089; P:fatty acid homeostasis; IEA:Ensembl.
DR   GO; GO:0006631; P:fatty acid metabolic process; IBA:GO_Central.
DR   GO; GO:0006072; P:glycerol-3-phosphate metabolic process; IBA:GO_Central.
DR   GO; GO:0070236; P:negative regulation of activation-induced cell death of T cells; IEA:Ensembl.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0006655; P:phosphatidylglycerol biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0055091; P:phospholipid homeostasis; IEA:Ensembl.
DR   GO; GO:0042104; P:positive regulation of activated T cell proliferation; IEA:Ensembl.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0001817; P:regulation of cytokine production; IEA:Ensembl.
DR   GO; GO:0009749; P:response to glucose; IEA:Ensembl.
DR   GO; GO:0019432; P:triglyceride biosynthetic process; IDA:UniProtKB.
DR   CDD; cd07993; LPLAT_DHAPAT-like; 1.
DR   InterPro; IPR022284; GPAT/DHAPAT.
DR   InterPro; IPR045520; GPAT/DHAPAT_C.
DR   InterPro; IPR041728; GPAT/DHAPAT_LPLAT.
DR   InterPro; IPR028354; GPAT_PlsB.
DR   InterPro; IPR002123; Plipid/glycerol_acylTrfase.
DR   PANTHER; PTHR12563; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; 1.
DR   PANTHER; PTHR12563:SF16; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE 1, MITOCHONDRIAL; 1.
DR   Pfam; PF01553; Acyltransferase; 1.
DR   Pfam; PF19277; GPAT_C; 1.
DR   PIRSF; PIRSF500064; GPAT; 1.
DR   PIRSF; PIRSF000437; GPAT_DHAPAT; 1.
DR   SMART; SM00563; PlsC; 1.
DR   SUPFAM; SSF69593; Glycerol-3-phosphate (1)-acyltransferase; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Acyltransferase; Lipid biosynthesis;
KW   Lipid metabolism; Membrane; Mitochondrion; Mitochondrion outer membrane;
KW   Phospholipid biosynthesis; Phospholipid metabolism; Phosphoprotein;
KW   Reference proteome; Transferase; Transit peptide; Transmembrane;
KW   Transmembrane helix.
FT   TRANSIT         1..?
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           ?..828
FT                   /note="Glycerol-3-phosphate acyltransferase 1,
FT                   mitochondrial"
FT                   /id="PRO_0000024690"
FT   TOPO_DOM        ?..471
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        472..494
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        495..574
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        575..593
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        594..828
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000255"
FT   REGION          435..455
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           230..235
FT                   /note="HXXXXD motif"
FT   COMPBIAS        439..455
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         380
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P97564"
FT   MOD_RES         688
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61586"
FT   MOD_RES         695
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18318008,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         780
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61586"
FT   MOD_RES         784
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61586"
FT   VARIANT         4
FT                   /note="S -> Y (in dbSNP:rs11549703)"
FT                   /id="VAR_050585"
FT   VARIANT         43
FT                   /note="I -> V (in dbSNP:rs2792751)"
FT                   /id="VAR_050586"
FT   VARIANT         131
FT                   /note="E -> G (in dbSNP:rs10787428)"
FT                   /id="VAR_050587"
FT   VARIANT         386
FT                   /note="I -> T (in dbSNP:rs35019520)"
FT                   /id="VAR_050588"
FT   CONFLICT        204
FT                   /note="I -> F (in Ref. 1; CAD89932)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        652
FT                   /note="Q -> R (in Ref. 1; CAD89932)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   828 AA;  93795 MW;  7AADD21BC8684693 CRC64;
     MDESALTLGT IDVSYLPHSS EYSVGRCKHT SEEWGECGFR PTIFRSATLK WKESLMSRKR
     PFVGRCCYSC TPQSWDKFFN PSIPSLGLRN VIYINETHTR HRGWLARRLS YVLFIQERDV
     HKGMFATNVT ENVLNSSRVQ EAIAEVAAEL NPDGSAQQQS KAVNKVKKKA KRILQEMVAT
     VSPAMIRLTG WVLLKLFNSF FWNIQIHKGQ LEMVKAATET NLPLLFLPVH RSHIDYLLLT
     FILFCHNIKA PYIASGNNLN IPIFSTLIHK LGGFFIRRRL DETPDGRKDV LYRALLHGHI
     VELLRQQQFL EIFLEGTRSR SGKTSCARAG LLSVVVDTLS TNVIPDILII PVGISYDRII
     EGHYNGEQLG KPKKNESLWS VARGVIRMLR KNYGCVRVDF AQPFSLKEYL ESQSQKPVSA
     LLSLEQALLP AILPSRPSDA ADEGRDTSIN ESRNATDESL RRRLIANLAE HILFTASKSC
     AIMSTHIVAC LLLYRHRQGI DLSTLVEDFF VMKEEVLARD FDLGFSGNSE DVVMHAIQLL
     GNCVTITHTS RNDEFFITPS TTVPSVFELN FYSNGVLHVF IMEAIIACSL YAVLNKRGLG
     GPTSTPPNLI SQEQLVRKAA SLCYLLSNEG TISLPCQTFY QVCHETVGKF IQYGILTVAE
     HDDQEDISPS LAEQQWDKKL PEPLSWRSDE EDEDSDFGEE QRDCYLKVSQ SKEHQQFITF
     LQRLLGPLLE AYSSAAIFVH NFSGPVPEPE YLQKLHKYLI TRTERNVAVY AESATYCLVK
     NAVKMFKDIG VFKETKQKRV SVLELSSTFL PQCNRQKLLE YILSFVVL
//
